TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive Improved Therapies For Cervical Cancer Said To Show Promise In Clinical Trials March 26, 2004
TCL Archive Cancer Control Awards $1 .5 Million Grant For 3-Year Study By College Of Radiology April 26, 1974